Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mr. Pink's Picks: selected event-driven value investments -- Ignore unavailable to you. Want to Upgrade?

To: valueminded who wrote (1893)	7/25/1998 11:48:00 AM
From: Mr. Burnt Sienna	Read Replies (1) \| Respond to of 18998

Perhaps we need to have an in-depth look at DOSE. On July 15, Mr. Pink posted: <<This market hates small cap stocks. Look for value in bigger caps. DOSE is cheap, but a hold. >> Now he posts: << Sold BEV some time ago, dose is a nightmare and just preannounced. sell dose too. Mr. Pink >> If I go back this spring, there were more than a few times that Mr. Pink beat the drum for DOSE. What's changed? Is this a "street" phenomenon? Is it a "fund" phenomenon? Was this a 'pump and dump' exercise? Is this company having problems? Is it a 'sector' issue? -BEV's problems seem to be Medicare labor costs in nursing homes. Does this tar DOSE. Is there a cross-over risk? - MDM has also cratered, but within it Caremark is doing well - setting targets and hitting them. DOSE aside from a 9% ownership by CXSNF, has a relationship with them. Is this a problem? Stadlander's by reputation isn't great shakes. I've got a lot of questions, but few answers. Since Mr. Pink has been the big advocate of DOSE, I'll post here. Mr. BS